Ophir High Conviction Fund (ASX: OPH) (“OPH” or the “Fund”) is a listed investment trust (LIT) that provides exposure to a concentrated portfolio of mid and small cap Australian and New Zealand listed securities. The Trust listed in December 2018, converting from an unlisted unit trust (“Unlisted Fund”). The Unlisted Fund had an inception date of August 2015 and had …

We have completed an update report for Acurx following the release of the June quarterly results and business update on 9 August 2024. The key takeaways from the report are: To view the report click here.

Markets were up in July with positive share price movement for a number of pharma and biotech stocks. Biotechs were also well supported in the US in July, with the iShares Biotech ETF up 7.8%. In this edition of Movers & Shakers for Pharma & Biotech we take a look at five ASX-listed companies whose share prices rallied in July.

In this edition of the IIR LMI Monthly Update we take a look at the key news for July as well as the key data points as at 30 June 2024. We also take a look at the FY24 results that have been released already.

We have updated our research coverage of Matsa Resources (ASX: MAT). Matsa has a gold Resource of 936Koz at 2.5g/t and is close to producing from its Devon gold mine, and is finalising the mining and processing contracts and obtaining funding. Devon is small but material, with cash flow likely to exceed the company’s current market capitalization, and a similar …